Cargando…
Fundamental effects of PD-1 antibody on the body: a brief report
We report the case of a 61-year-old man with squamous cell carcinoma of the left lung and mediastinal lymph node metastases who received nivolumab and experienced a better antitumor effect than expected but died soon afterward. A clinical analysis showed that the grades of the treatment-related even...
Autores principales: | Wang, Wei, Liu, Bing, Liu, Guangxian, Guo, Wanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939985/ https://www.ncbi.nlm.nih.gov/pubmed/27462168 http://dx.doi.org/10.2147/OTT.S104766 |
Ejemplares similares
-
Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review
por: Li, Wei, et al.
Publicado: (2020) -
Treatment of PD-1 Inhibitor-Associated Toxic Epidermal Necrolysis: A Case Report and Brief Review
por: Zhao, Yidong, et al.
Publicado: (2022) -
Tuberculous Lymphadenitis in a Patient Receiving PD-1 Inhibitor for Melanoma: A Case Report and Brief Literature Review
por: Akagunduz, Baran, et al.
Publicado: (2021) -
Successful Treatment of Metastatic Gallbladder Carcinoma with PD-L1 Expression by the Combination of PD-1 Inhibitor Plus Bevacizumab with Chemotherapy: A Case Report
por: Guo, Lihong, et al.
Publicado: (2022) -
Anesthetic management of carotid body tumor excision: A case report and brief review
por: Karigar, Shivanand L., et al.
Publicado: (2014)